Imrecoxib is a chemical compound under investigation as an active pharmaceutical ingredient. It has been evaluated in clinical trials for the management of knee osteoarthritis.
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
4-(4-methylphenyl)-3-(4-methylsulfonylphenyl)-1-propyl-2H-pyrrol-5-one
AXMZZGKKZDJGAZ-UHFFFAOYSA-N
CCCN1CC(=C(C1=O)C2=CC=C(C=C2)C)C3=CC=C(C=C3)S(=O)(=O)C